Steep rise in health burden of osteoarthritis Greater life expectancy, increasing obesity and expanding populations are all factors in the increase, a new study suggests.
How does Omicron compare with Delta? Infectious diseases physician Sanjaya Senanayake details what is known about infectiousness, symptoms, severity and vaccine protection.
Novavax given limited approval as booster New ATAGI advice permits Novavax for third dose and encourages those who had AstraZeneca as primary course to take mRNA booster.
First COVID-19 antiviral receives PBS funding GPs can now prescribe molnupiravir for COVID-positive adult patients at risk of developing severe disease.
TGA provisionally approves first prevention therapy for COVID-19 The combination therapy, created by AstraZeneca, has been described as another ‘significant step forward’ in the pandemic.
How many people were ‘waiting for Novavax’? The approval of Novavax was long-awaited. Now its rollout is under way, newsGP assesses what response GPs are seeing on the ground.
Report highlights value of telehealth phone consultations The RACGP has welcomed the findings, which show the total number of GP consultations increased by 11% with the widespread introduction of telehealth.
Research links soluble paracetamol with increased risk of CVD A large study has revealed a connection between salt in soluble paracetamol with a significantly increased risk of heart attacks, stroke and death.
‘The war on drugs doesn’t work’: New bill shines light on old laws Legislation before the Victorian Parliament proposes decriminalising drug use. It may not pass but advocates for evidence-based health hope it has an impact.
ATAGI releases Moderna guidance for children aged 6–11 The RACGP has welcomed the announcement, but says more funding and support is needed for general practice.